Global Statin Market to decline at a CAGR of 7.50% over the period 2014-2019; Finds New Report

Report forecast the global statin market to decline at a CAGR of 7.50% over the period 2014-2019.

Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality. It has significant anti-inflammatory and plaque-stabilizing effects. Its other effects include decreased oxidative stress and vascular inflammation with increased atherosclerotic lesions. Some of the currently available statins are atorvastatin, lovastatin, rosuvastatin, and simvastatin.

This report covers the present scenario and the growth prospects of the global statin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of statins used for the management of lipid abnormalities and lipid-associated comorbidities such as stroke and coronary heart disease. This report provides a discussion of the market in the following three regions: Americas, APAC, and EMEA.

According to the report, sedentary lifestyles and increasing obesity worldwide are resulting in a rise in the levels of LDL cholesterol in the blood. Lipid metabolic disorders such as dyslipidemia expose a person to risk factors such as coronary heart disease – a leading cause of death worldwide. According to the WHO, dyslipidemia caused more than half of the global cases of coronary heart disease and resulted in over 4 million deaths, each year. North America has one of the highest prevalence of high cholesterol. Therefore, the demand for cholesterol-lowering drugs such as statins will increase, leading to positive growth in the market.

Further, the report states that the popularity of generics restricts pharmaceutical companies from investing in R&D for new statin molecules, thereby hindering market growth.

Global Statin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

key players in the Global Statin Market: AstraZeneca, Merck, Novartis and Pfizer

Other Prominent Vendors in the market are: Amgen, Aurobindo Pharma, Abbvie, Abbott, Biocon, BC World Pharm, Cipla, Concord Biotech, CKD Bio, CJ HealthCare Corporation, Cerenis Therapeutics, GlaxoSmithKline, HanAll BioPharma, JX Pharmaceuticals, Kowa, Lupin, Livzon, Mylan, Merz Pharmaceuticals, SUN Pharma, Teva, Torrent Pharmaceuticals and Zydus Cadila

Key Regions

• Americas
• APAC
• EMEA      

Market Driver

• Rising Number of High Cholesterol Cases
• For a full, detailed list, view our report

Market Challenge

• Lack of Novel Molecules in Statins Category
• For a full, detailed list, view our report

Market Trend

• Switch from Statins to Non-statins
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 81 pages and 30 Exhibits “Global Statin Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Product Profile, Statin: An Overview, Pipeline Portfolio, Market Landscape, Market Segmentation by Product Category, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4KZ

Find all Diseases Reports at: http://www.marketresearchreports.com/diseases